非常に強力な抗炎症性エポキシイソプロスタン由来ラクトンの発見
Julian Egger1, Peter Bretscher, Stefan Freigang
1Laboratory of Organic Chemistry, ETH Zurich , HCI H335, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland.
Journal of the American Chemical Society
|December 5, 2014
まとめ
エポキシイソプロスタンEIとECは,炎症誘発性サイトカインを効果的に抑制する. EIとECから形成される可能性が高い強力なラクトン誘導体が特定され,新しい分子機構が明らかになりました.
科学分野:
- バイオケミストリー バイオケミストリー
- 免疫学 免疫学とは
- 有機化学 オーガニック・ケミストリー
背景:
- エポキシイソプロスタン (EIとEC) は,炎症性サイトカイン分泌の阻害剤として知られています.
- インタールイウキン-6 (IL-6) とインタールイウキン-12 (IL-12) は,炎症反応に関与する重要なサイトカインです.
研究 の 目的:
- エポキシイソプロスタンEIとECの分子作用機構を調査する.
- 新規デリバティブを特定し,その形成経路を理解する.
主な方法:
- エポキシイソプロスタンEI (1) とEC (2) の詳細な化学研究は行われました.
- 分析は,分子内反応を調査し,その結果生成された化合物を特定することを含む.
主要な成果:
- 非常に強力なラクトン誘導体 (3) が特定されました.
- イソプロスタノイドEI (1) とEC (2) はラクトンの前駆体として提案されている (3).
- ラクトン (3) は,EC (2) のエポキシドとカルボキシル酸の間の分子内反応によって形成されます.
結論:
- エポキシイソプロスタンEIとECは,IL-6とIL-12の分泌を阻害することで強力な抗炎症性を持っています.
- EIとECから派生した新しい,非常に強力なラクトン誘導体 (3) が特定されました.
- EIとECからラクトン (3) の形成は,これらの化合物の分子経路の洞察を提供します.
さらに関連する動画
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
2.0K
08:56Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
3.6K
関連する概念動画
01:19Antiasthma Drugs: Leukotriene Modifiers
2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.3K
03:00Preparation of Epoxides
10.2K
Overview
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy...
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy...
10.2K
02:24Acid-Catalyzed Ring-Opening of Epoxides
10.1K
Epoxides that are three-membered ring systems are more reactive than other cyclic and acyclic ethers. The high reactivity of epoxides originates from the strain present in the ring. This ring strain acts as a driving force for epoxides to undergo ring-opening reactions either with halogen acids or weak nucleophiles in the presence of mild acid. The acid catalyst converts the epoxide oxygen, a poor leaving group, into an oxonium ion, a better leaving group, making the reaction feasible. The...
10.1K
02:57Sharpless Epoxidation
5.5K
The conversion of allylic alcohols into epoxides using the chiral catalyst was discovered by K. Barry Sharpless and is known as Sharpless epoxidation. The use of a chiral catalyst enables the formation of one enantiomer of the product in excess. This chiral catalyst is mainly a chiral complex of titanium tetraisopropoxide and tartrate ester (specific stereoisomer). The stereoisomer used in the chiral catalyst dictates the formation of the enantiomer of the product. In other words, the use of...
5.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.5K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
626
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
626